Stacey Ruiz - Concepedia

Author

Stacey Ruiz

Reata Pharmaceuticals (United States)

Also Known As

S. RUIZ, S. Ruiz, Stacey L. Ruiz, Stacey Ruiz

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Reata Pharmaceuticals (United States)Renal Associates P. A.University of Alabama at Birmingham Statistics Collaborative The University of Texas Southwestern Medical Center

About

Stacey Ruiz is an author at Reata Pharmaceuticals (United States) specializing in medicine, clinical trial evaluation, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	332
2	Health Sciences	1	1	53
3	Allergy	1	1	49
4	Cell Biology	1	1	49
5	Diabetes	1	1	230

Stacey Ruiz

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes Pablo E. Pérgola, Philip Raskin, Robert D. Toto, New England Journal of Medicine	2011	868
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer Toshiro Migita, Stacey Ruiz, A Fornari, JNCI Journal of the National Cancer Institute	2009	381
Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD Pablo E. Pérgola, Melissa Krauth, Jesse W. Huff, American Journal of Nephrology Renal InflammationKidney FunctionOxidative StressInflammationGlomerulonephritis	2011	230
The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia Stacey Ruiz, Yelena V. Krupnik, Michael J. Keating, Molecular Cancer Therapeutics	2006	108
Triterpenoid Dihydro-CDDO-Trifluoroethyl Amide Protects against Maladaptive Cardiac Remodeling and Dysfunction in Mice: A Critical Role of Nrf2 Yifan Xing, Ting Niu, Wenjuan Wang, PLoS ONE	2012	61
Late breaking clinical trials 1 C. G. M. Kallenberg, Ulrich Specks, John H. Stone, Clinical Kidney Journal Clinical Trials 1Clinical Trial ManagementClinical Trial AnalysisClinical EndpointClinical Studies	2011	53
CD20 and CD5 Expression in B‐Chronic Lymphocytic Leukemia Gerald E. Marti, Guy B. Faguet, Pablo Bertín, Annals of the New York Academy of Sciences Hematological MalignancyAllergyAutoimmune DiseaseNormal B-pblLymphocyte Development	1992	49
Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. Jessica Pahler, Stacey Ruiz, Irina Niemer, PubMed	2003	47
Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice Pontus Dunér, Ingrid Yao Mattisson, Per Fogelstrand, Scientific Reports	2021	24

Page 1